Breeze Holdings Acquisition Corp. shareholders approved the business combination with YD Biopharma Limited.
The combined company will be named YD Bio Limited and trade on Nasdaq under ticker symbol 'YDES'.
Approval was received at a special meeting of stockholders, with overwhelming support for the Business Combination Proposal.
Approval of Business Combination
Stockholders voted in favor of the business combination with YD Biopharma Limited.
New Ticker Symbol
The combined company will trade on Nasdaq using the ticker symbol 'YDES'.
Closing Timeline
The closing of the transaction is expected within the next two weeks.
Legal and Financial Advisors
ArentFox Schiff LLP and I-Bankers Securities, Inc. are among the advisors for the transaction.
- The approval of the business combination signals confidence in the future prospects of the combined company.
- Trading on Nasdaq under the new ticker symbol 'YDES' opens up new opportunities for visibility and investor interest.
The approval of the business combination between Breeze Holdings Acquisition Corp. and YD Biopharma Limited sets the stage for a transformative journey as YD Bio Limited on the Nasdaq market.